OPTUS Pharmaceutical Co., Ltd.
Develops and manufactures ophthalmic solutions for dry eye, infections, and inflammation.
131030 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청주시 흥덕구 오송읍 오송생명6로 50, 청주시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
OPTUS Pharmaceutical Co., Ltd. (formerly DHP Korea Co Ltd) is a specialized pharmaceutical company dedicated to providing total eye care solutions. The company develops, manufactures, and markets a comprehensive portfolio of ophthalmic products targeting conditions such as dry eye syndrome, bacterial infections, and inflammation. Its product line includes preservative-free artificial tears and medicated eye drops with active ingredients like sodium hyaluronate, cyclosporine, and moxifloxacin. OPTUS Pharmaceutical operates a dedicated, GMP-compliant manufacturing plant that specializes in producing single-dose ophthalmic preparations, ensuring high standards of safety and quality. The company is committed to continuous research and innovation in eye health and also provides contract manufacturing services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 994.7 KB | ||
| 2025-07-09 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 64.5 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 898.2 KB | ||
| 2025-04-15 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 17.0 KB | ||
| 2025-04-09 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 30.2 KB | ||
| 2025-03-25 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 33.7 KB | ||
| 2025-03-25 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 18.4 KB | ||
| 2025-03-25 00:00 |
Board/Management Information
대표이사변경
|
Korean | 9.1 KB | ||
| 2025-03-17 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.1 MB | ||
| 2025-03-13 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 17.6 KB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
|
Korean | 135.1 KB | ||
| 2025-03-10 00:00 |
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
|
Korean | 126.7 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 19.1 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 120.2 KB | ||
| 2025-03-07 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 111.4 KB |
Automate Your Workflow. Get a real-time feed of all OPTUS Pharmaceutical Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for OPTUS Pharmaceutical Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
